| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.992 | 0.001 | 0.992 | Insulin sensitizer | 0.92 0.001 DBMET03335 0.533 0.004 DBMET03336 0.431 0.005 DBMET03337 | ||
| 0.836 | 0 | 0.836 | Angiotensin II receptor antagonist | 0.69 0.001 DBMET03335 0.325 0.001 DBMET03336 0.125 0.002 DBMET03337 | ||
| 0.792 | 0 | 0.792 | Angiotensin AT1 receptor antagonist | 0.671 0.001 DBMET03335 0.309 0.001 DBMET03336 0.098 0.003 DBMET03337 | ||
| 0.67 | 0.017 | 0.67 | Cyclophilin D inhibitor | 0.541 0.04 DBMET03335 0.541 0.039 DBMET03336 0.241 0.224 DBMET03337 | ||
| 0.3 | 0.005 | 0.3 | Peroxisome proliferator-activated receptor gamma agonist | 0.075 0.044 DBMET03335 | ||
| 0.27 | 0.059 | 0.27 | Hypolipemic | |||
| 0.209 | 0.018 | 0.209 | Xanthine oxidase inhibitor | |||
| 0.214 | 0.036 | 0.214 | NOS3 expression enhancer | |||
| 0.157 | 0.01 | 0.157 | Interleukin 5 antagonist | 0.085 0.062 DBMET03335 0.108 0.033 DBMET03337 | ||
| 0.159 | 0.021 | 0.159 | Breast cancer-resistant protein inhibitor | |||
| 0.119 | 0.003 | 0.14 | Angiotensin AT2 receptor antagonist | 0.14 0.003 DBMET03335 0.128 0.003 DBMET03336 0.07 0.006 DBMET03337 | DBMET03335 | |
| 0.172 | 0.067 | 0.172 | Thrombolytic | |||
| 0.275 | 0.18 | 0.275 | Calcium channel L-type activator | |||
| 0.2 | 0.109 | 0.2 | Tumour necrosis factor alpha release inhibitor | |||
| 0.082 | 0.012 | 0.082 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.089 | 0.021 | 0.089 | Maillard reaction inhibitor | |||
| 0.082 | 0.034 | 0.082 | Potassium channel large-conductance Ca-activated activator | |||
| 0.051 | 0.005 | 0.051 | Elastase 2 inhibitor | |||
| 0.051 | 0.005 | 0.051 | Elastase 2A inhibitor | |||
| 0.073 | 0.029 | 0.076 | Nitric oxide donor | 0.076 0.026 DBMET03335 | DBMET03335 | |
| 0.039 | 0.009 | 0.039 | Elastase 3B inhibitor | |||
| 0.039 | 0.009 | 0.039 | Elastase 2B inhibitor | |||
| 0.039 | 0.009 | 0.039 | Elastase 3A inhibitor | |||
| 0.034 | 0.005 | 0.069 | Angiotensin AT1A receptor antagonist | 0.069 0.003 DBMET03335 0.054 0.004 DBMET03336 0.042 0.004 DBMET03337 | DBMET03335 | |
| 0.064 | 0.041 | 0.064 | Glutamate (mGluR) agonist | |||
| 0.167 | 0.152 | 0.167 | Hypoglycemic | |||
| 0.168 | 0.154 | 0.356 | Cardiotonic | 0.321 0.048 DBMET03335 0.356 0.038 DBMET03336 0.172 0.149 DBMET03337 | DBMET03336 | |
| 0.084 | 0.075 | 0.084 | Uric acid excretion stimulant | |||
| 0.019 | 0.015 | 0.019 | Retinoic acid beta receptor agonist | |||
| 0.036 | 0.033 | 0.036 | Retinoic acid alpha receptor agonist | |||
| 0.042 | 0.039 | 0.042 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.106 | 0.107 | 0.22 | Interleukin 4 antagonist | 0.176 0.032 DBMET03335 0.22 0.018 DBMET03337 | DBMET03337 | |
| 0.009 | 0.018 | 0.026 | Angiotensin AT1B receptor antagonist | 0.026 0.004 DBMET03335 0.023 0.005 DBMET03336 0.018 0.007 DBMET03337 | DBMET03335 | |
| 0.188 | 0.217 | 0.407 | Toll-Like receptor 7 agonist | 0.407 0.057 DBMET03335 0.335 0.09 DBMET03336 0.362 0.076 DBMET03337 | DBMET03335 | |
| 0.042 | 0.077 | 0.08 | Phosphodiesterase III inhibitor | 0.08 0.036 DBMET03335 0.07 0.043 DBMET03336 | DBMET03335 | |
| 0.052 | 0.088 | 0.084 | Glutamate receptor agonist | 0.084 0.049 DBMET03336 | DBMET03336 | |
| 0.183 | 0.225 | 0.404 | Toll-Like receptor agonist | 0.404 0.059 DBMET03335 0.328 0.094 DBMET03336 0.363 0.076 DBMET03337 | DBMET03335 | |
| 0.013 | 0.079 | 0.029 | Bradykinin B2 receptor agonist | 0.029 0.019 DBMET03337 | DBMET03337 | |
| 0.006 | 0.103 | 0.014 | Calcium-sensing receptor antagonist | 0.014 0.012 DBMET03337 | DBMET03337 | |
| 0.107 | 0.213 | 0.135 | CC chemokine 6 receptor antagonist | 0.127 0.082 DBMET03335 0.135 0.053 DBMET03336 0.134 0.058 DBMET03337 | DBMET03336 | |
| 0.029 | 0.155 | 0.05 | Autotaxin inhibitor | 0.05 0.041 DBMET03335 | DBMET03335 | |
| 0.097 | 0.222 | 0.205 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.163 0.051 DBMET03335 0.205 0.016 DBMET03336 | DBMET03336 | |
| 0.094 | 0.234 | 0.459 | Platelet antagonist | 0.459 0.018 DBMET03337 | DBMET03337 | |
| 0.006 | 0.158 | 0.082 | Endothelin receptor antagonist | 0.082 0.006 DBMET03335 0.05 0.01 DBMET03336 | DBMET03335 | |
| 0.005 | 0.163 | 0.054 | Endothelin A receptor antagonist | 0.054 0.005 DBMET03335 0.028 0.011 DBMET03336 | DBMET03335 | |
| 0.066 | 0.229 | 0.518 | Anticoagulant | 0.518 0.009 DBMET03337 | DBMET03337 | |
| 0.023 | 0.191 | 0.058 | Cytokine production stimulant | 0.048 0.033 DBMET03335 0.058 0.015 DBMET03337 | DBMET03337 | |
| 0.016 | 0.188 | 0.136 | Plasminogen activator inhibitor | 0.136 0.008 DBMET03337 | DBMET03337 | |
| 0.01 | 0.197 | 0.055 | Phosphodiesterase 3B inhibitor | 0.055 0.022 DBMET03335 | DBMET03335 | |
| 0.009 | 0.196 | 0.033 | Nicotinic acid receptor 2 agonist | 0.033 0.028 DBMET03335 | DBMET03335 | |
| 0.02 | 0.225 | 0.061 | Myc inhibitor | 0.061 0.028 DBMET03336 | DBMET03336 | |
| 0.023 | 0.236 | 0.112 | Factor IXa inhibitor | 0.112 0.007 DBMET03337 | DBMET03337 | |
| 0.004 | 0.22 | 0.068 | Endothelin B receptor antagonist | 0.068 0.005 DBMET03335 0.051 0.005 DBMET03336 | DBMET03335 | |
| 0.107 | 0.336 | 0.273 | Immunomodulator | 0.273 0.098 DBMET03337 | DBMET03337 | |
| 0.005 | 0.246 | 0.07 | Factor XI inhibitor | 0.046 0.012 DBMET03335 0.07 0.005 DBMET03336 | DBMET03336 | |
| 0.009 | 0.255 | 0.042 | Glutamate (mGluR group II) agonist | 0.034 0.025 DBMET03335 0.042 0.019 DBMET03336 | DBMET03336 | |
| 0.006 | 0.273 | 0.033 | Glutamate (mGluR2) agonist | 0.033 0.022 DBMET03336 | DBMET03336 | |
| 0.092 | 0.359 | 0.198 | Cholesterol antagonist | 0.198 0.166 DBMET03337 | DBMET03337 | |
| 0.014 | 0.29 | 0.067 | Acid-sensing ion channel blocker | 0.067 0.007 DBMET03337 | DBMET03337 | |
| 0.038 | 0.327 | 0.095 | Phosphodiesterase 7B inhibitor | 0.095 0.063 DBMET03336 | DBMET03336 | |
| 0.005 | 0.322 | 0.061 | Plasma kallikrein inhibitor | 0.054 0.011 DBMET03335 0.061 0.009 DBMET03336 0.051 0.012 DBMET03337 | DBMET03336 | |
| 0.011 | 0.357 | 0.087 | Kallikrein inhibitor | 0.056 0.026 DBMET03335 0.068 0.019 DBMET03336 0.087 0.013 DBMET03337 | DBMET03337 | |
| 0.021 | 0.377 | 0.08 | Interferon inducer | 0.08 0.024 DBMET03337 | DBMET03337 | |
| 0.006 | 0.373 | 0.062 | Factor Xa inhibitor | 0.062 0.023 DBMET03337 | DBMET03337 | |
| 0.018 | 0.405 | 0.1 | Interferon agonist | 0.1 0.028 DBMET03337 | DBMET03337 | |
| 0.032 | 0.42 | 0.132 | Phospholipase A2 inhibitor | 0.132 0.097 DBMET03337 | DBMET03337 | |
| 0.011 | 0.421 | 0.032 | Purinergic P2Y2 antagonist | 0.032 0.027 DBMET03336 | DBMET03336 | |
| 0.02 | 0.444 | 0.3 | Ribosomal protein S6 kinase inhibitor | 0.251 0.02 DBMET03335 0.3 0.011 DBMET03336 | DBMET03336 | |
| 0.05 | 0.476 | 0.109 | Factor V inhibitor | 0.109 0.052 DBMET03337 | DBMET03337 | |
| 0.095 | 0.543 | 0.442 | Antiinflammatory | 0.43 0.121 DBMET03335 0.442 0.115 DBMET03336 | DBMET03336 | |
| 0.005 | 0.467 | 0.038 | AMPA receptor agonist | 0.034 0.028 DBMET03335 0.038 0.02 DBMET03336 | DBMET03336 | |
| 0.003 | 0.467 | 0.087 | GP IIb/IIIa receptor antagonist | 0.087 0.02 DBMET03337 | DBMET03337 | |
| 0.02 | 0.489 | 0.975 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.96 0.002 DBMET03335 0.975 0.002 DBMET03336 | DBMET03336 | |
| 0.003 | 0.479 | 0.391 | Cholecystokinin B antagonist | 0.272 0.004 DBMET03335 0.391 0.003 DBMET03336 | DBMET03336 | |
| 0.001 | 0.507 | 0.225 | Kainate receptor 1 antagonist | 0.031 0.01 DBMET03335 0.225 0.003 DBMET03336 | DBMET03336 | |
| 0.005 | 0.53 | 0.125 | Plasmin inhibitor | 0.125 0.013 DBMET03337 | DBMET03337 | |
| 0.004 | 0.55 | 0.366 | Cholecystokinin antagonist | 0.277 0.004 DBMET03335 0.366 0.004 DBMET03336 | DBMET03336 | |
| 0.022 | 0.579 | 0.116 | Kallikrein 1 inhibitor | 0.116 0.01 DBMET03337 | DBMET03337 | |
| 0.007 | 0.564 | 0.065 | Rho-associated kinase inhibitor | 0.065 0.06 DBMET03336 | DBMET03336 | |
| 0.014 | 0.606 | 0.743 | Death-associated protein kinase 3 inhibitor | 0.671 0.004 DBMET03335 0.743 0.003 DBMET03336 | DBMET03336 | |
| 0.005 | 0.617 | 0.042 | Tryptase inhibitor | 0.042 0.019 DBMET03337 | DBMET03337 | |
| 0.007 | 0.629 | 0.279 | Alcohol dehydrogenase inhibitor | 0.179 0.015 DBMET03335 0.279 0.006 DBMET03336 | DBMET03336 | |
| 0.004 | 0.629 | 0.073 | Trypsin II inhibitor | 0.073 0.005 DBMET03337 | DBMET03337 | |
| 0.008 | 0.632 | 0.598 | CDC-like kinase 2 inhibitor | 0.484 0.007 DBMET03335 0.598 0.005 DBMET03336 | DBMET03336 | |
| 0.002 | 0.632 | 0.248 | Kainate receptor antagonist | 0.053 0.019 DBMET03335 0.248 0.003 DBMET03336 | DBMET03336 | |
| 0.007 | 0.645 | 0.436 | CDC-like kinase 4 inhibitor | 0.317 0.028 DBMET03335 0.436 0.011 DBMET03336 | DBMET03336 | |
| 0.004 | 0.645 | 0.035 | Factor IX inhibitor | 0.035 0.005 DBMET03337 | DBMET03337 | |
| 0.011 | 0.664 | 0.823 | Protein kinase (CK1) gamma 3 inhibitor | 0.765 0.003 DBMET03335 0.823 0.003 DBMET03336 | DBMET03336 | |
| 0.081 | 0.734 | 0.28 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.28 0.242 DBMET03337 | DBMET03337 | |
| 0.046 | 0.702 | 0.139 | Catenin beta inhibitor | 0.139 0.134 DBMET03336 | DBMET03336 | |
| 0.008 | 0.665 | 0.679 | Protein kinase (CK1) gamma 2 inhibitor | 0.562 0.004 DBMET03335 0.679 0.003 DBMET03336 | DBMET03336 | |
| 0.01 | 0.683 | 0.719 | Protein kinase (CK1) gamma 1 inhibitor | 0.65 0.004 DBMET03335 0.719 0.003 DBMET03336 | DBMET03336 | |
| 0.004 | 0.679 | 0.141 | Factor VII inhibitor | 0.141 0.005 DBMET03337 | DBMET03337 | |
| 0.005 | 0.682 | 0.203 | Glutamate receptor antagonist | 0.13 0.065 DBMET03335 0.203 0.025 DBMET03336 | DBMET03336 | |
| 0.006 | 0.693 | 0.023 | Complement factor 1 inhibitor | 0.023 0.006 DBMET03337 | DBMET03337 | |
| 0.011 | 0.733 | 0.644 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.512 0.008 DBMET03335 0.644 0.005 DBMET03336 | DBMET03336 | |
| 0.005 | 0.73 | 0.664 | Protein kinase (CK1) gamma inhibitor | 0.562 0.004 DBMET03335 0.664 0.004 DBMET03336 | DBMET03336 | |
| 0.004 | 0.739 | 0.197 | Factor VIIa inhibitor | 0.197 0.005 DBMET03337 | DBMET03337 | |
| 0.005 | 0.746 | 0.337 | Clk dual-specificity kinase inhibitor | 0.218 0.069 DBMET03335 0.337 0.03 DBMET03336 | DBMET03336 | |
| 0.009 | 0.752 | 0.677 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.594 0.004 DBMET03335 0.677 0.004 DBMET03336 | DBMET03336 | |
| 0.005 | 0.751 | 0.159 | Thrombin inhibitor | 0.159 0.01 DBMET03337 | DBMET03337 | |
| 0.013 | 0.76 | 0.307 | Insulin secretagoues | 0.307 0.012 DBMET03335 0.251 0.019 DBMET03336 | DBMET03335 | |
| 0.008 | 0.761 | 0.792 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.695 0.004 DBMET03335 0.792 0.004 DBMET03336 | DBMET03336 | |
| 0.004 | 0.762 | 0.446 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.277 0.057 DBMET03335 0.446 0.019 DBMET03336 | DBMET03336 | |
| 0.01 | 0.771 | 0.301 | MAP kinase 13 inhibitor | 0.243 0.012 DBMET03335 0.301 0.005 DBMET03336 | DBMET03336 | |
| 0.005 | 0.768 | 0.158 | MAP kinase 8 inhibitor | 0.158 0.027 DBMET03335 0.149 0.03 DBMET03336 | DBMET03335 | |
| 0.004 | 0.774 | 0.403 | Dyrk kinase inhibitor | 0.249 0.072 DBMET03335 0.403 0.025 DBMET03336 | DBMET03336 | |
| 0.009 | 0.784 | 0.234 | Platelet aggregation inhibitor | 0.234 0.059 DBMET03337 | DBMET03337 | |
| 0.021 | 0.796 | 0.11 | DNA repair enzyme inhibitor | 0.11 0.095 DBMET03337 | DBMET03337 | |
| 0.007 | 0.79 | 0.042 | Glutamate (mGluR4) antagonist | 0.042 0.033 DBMET03336 | DBMET03336 | |
| 0.004 | 0.788 | 0.316 | Protein kinase (CK1) delta inhibitor | 0.235 0.019 DBMET03335 0.316 0.011 DBMET03336 | DBMET03336 | |
| 0.009 | 0.795 | 0.773 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.672 0.004 DBMET03335 0.773 0.003 DBMET03336 | DBMET03336 | |
| 0.01 | 0.817 | 0.108 | Factor III inhibitor | 0.108 0.004 DBMET03337 | DBMET03337 | |
| 0.005 | 0.814 | 0.589 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.466 0.005 DBMET03335 0.589 0.004 DBMET03336 | DBMET03336 | |
| 0.003 | 0.817 | 0.088 | Trypsin I inhibitor | 0.088 0.007 DBMET03337 | DBMET03337 | |
| 0.004 | 0.82 | 0.154 | Protein kinase A inhibitor | 0.092 0.051 DBMET03335 0.154 0.023 DBMET03336 | DBMET03336 | |
| 0.004 | 0.826 | 0.152 | Urokinase inhibitor | 0.152 0.007 DBMET03337 | DBMET03337 | |
| 0.003 | 0.826 | 0.182 | Factor X inhibitor | 0.182 0.006 DBMET03337 | DBMET03337 | |
| 0.005 | 0.835 | 0.157 | Protein kinase C delta inhibitor | 0.125 0.034 DBMET03335 0.157 0.018 DBMET03336 | DBMET03336 | |
| 0.004 | 0.834 | 0.253 | Protein kinase (CK1) inhibitor | 0.167 0.055 DBMET03335 0.253 0.025 DBMET03336 | DBMET03336 | |
| 0.007 | 0.839 | 0.437 | Polo-like kinase-3 inhibitor | 0.374 0.004 DBMET03335 0.437 0.004 DBMET03336 | DBMET03336 | |
| 0.006 | 0.852 | 0.145 | Trypsin inhibitor | 0.145 0.008 DBMET03337 | DBMET03337 | |
| 0.008 | 0.856 | 0.759 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.636 0.004 DBMET03335 0.759 0.004 DBMET03336 | DBMET03336 | |
| 0.004 | 0.86 | 0.217 | Polo-like kinase-4 inhibitor | 0.159 0.03 DBMET03335 0.217 0.012 DBMET03336 | DBMET03336 | |
| 0.001 | 0.867 | 0.039 | NMDA receptor subunit 3B antagonist | 0.039 0.037 DBMET03337 | DBMET03337 | |
| 0.004 | 0.874 | 0.167 | Pim-1 kinase inhibitor | 0.108 0.05 DBMET03335 0.167 0.022 DBMET03336 | DBMET03336 | |
| 0.016 | 0.887 | 0.306 | 5 Hydroxytryptamine release inhibitor | 0.306 0.158 DBMET03337 | DBMET03337 | |
| 0.002 | 0.882 | 0.181 | Glycogen synthase kinase-3 alpha inhibitor | 0.181 0.048 DBMET03336 | DBMET03336 | |
| 0.009 | 0.89 | 0.196 | HIV-1 integrase (Overall Integration) inhibitor | 0.196 0.013 DBMET03337 | DBMET03337 | |
| 0.002 | 0.884 | 0.084 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.084 0.03 DBMET03337 | DBMET03337 | |
| 0.006 | 0.897 | 0.506 | Aldehyde oxidase inhibitor | 0.506 0.032 DBMET03337 | DBMET03337 | |
| 0.005 | 0.911 | 0.196 | DNA synthesis inhibitor | 0.196 0.129 DBMET03337 | DBMET03337 | |
| 0.008 | 0.917 | 0.471 | Nootropic | 0.402 0.038 DBMET03335 0.471 0.024 DBMET03336 | DBMET03336 | |
| 0.009 | 0.922 | 0.195 | Superoxide dismutase inhibitor | 0.195 0.123 DBMET03337 | DBMET03337 | |
| 0.003 | 0.917 | 0.099 | Gastric antisecretory | 0.099 0.067 DBMET03335 0.092 0.076 DBMET03336 | DBMET03335 | |
| 0.001 | 0.919 | 0.135 | Protein kinase (CK2) inhibitor | 0.135 0.04 DBMET03336 | DBMET03336 | |
| 0.001 | 0.927 | 0.142 | Protein kinase (CK2) alpha inhibitor | 0.142 0.046 DBMET03336 | DBMET03336 | |
| 0.004 | 0.935 | 0.285 | Antithrombotic | 0.285 0.099 DBMET03337 | DBMET03337 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |